references - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/4982/12/12_references.pdf ·...
Post on 10-Nov-2018
216 Views
Preview:
TRANSCRIPT
References
108
REFERENCES 1. Elaine N Marieb. The integumentary system in Human Anatomy and physiology.
Chapter 5. 6th Ed., 152-166; Pearson Education Publishers, 2006.
2. Gerard J Tortora & Bryan Derrickson. The integumentary system in Principles of
Anatomy and physiology. Chapter 5. 11th Ed., 144-162; John Wiley & sons
Publishers, 2007.
3. Chein YW. Transdermal Drug delivery and delivery systems in Novel drug
delivery systems. Informa healthcare, New York, 2nd Ed., 301- 380; 2009.
4. Collier SW, Sheikh NM, Sakr A, Lichtin JL, Stewart RF, Bronaugh RL.
Maintenance of skin viability during in vitro percutaneous absorption/metabolism
studies. Toxicol Appl Pharmacol., 99:522-533; 1989.
5. Nathan D, Sakr A, Lichtin JL, Bronaugh RL. In vitro skin absorption and
metabolism of benzoic acid, p-aminobenzoic acid, and benzocaine in the hairless
guinea pig. Pharm Res., 7:1147-1151; 1990.
6. Pannatier A, Jenner P, Testa B, Etter JC. The skin as a drug metabolizing organ.
Drug Metab Rev., 8:319–343; 1978.
7. Dessiioti C, Antoniou C, Stratigos AJ. New targeted approaches for the
treatment and pevention of nonmelanoma skin cancer. Expet Rev Dermatol., 6:625-
634; 2011.
8. Lim HW, James WD, Rigel DS, Maloney ME, Spencer JM, Bhushan R. Adverse
effects of ultraviolet radiation from the use of indoor tanning equipment: time to ban
the tan. J Am Acad Dermatol., 64:893-902; 2011.
9. Schulman JM, Fisher DE. Indoor ultraviolet tanning and skin cancer: Health
risks and opportunities. Curr Opin Oncol., 21:144-149, 2009.
10. Veierød MB, Weiderpass E, Thörn M. A prospective study of pigmentation, sun
exposure, and risk of cutaneous malignant Melanoma in women. J Nat Cancer Inst.,
95:1530-1538; 2003.
11. Berwick M, Erdei E, Hay J. Melanoma Epidemiology and Public Health. Clin
Dermatol., 27:205-214; 2009.
References
109
12. Siegel R, Elizabeth W, Otis B, Ahmedin J. Cancer statistics, 2011: The impact of
eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A
Cancer J. Clin., 61:212-236; 2011.
13. Zheng D, Li X, Xu H, Lu X, Hu Y, Fan W. Study on docetaxel-loaded
nanoparticles with high antitumor efficacy against malignant melanoma. Acta
Biochem Biophys Sin., 41: 578-587; 2009.
14. Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol
Oncol: Seminars and Original Investigations . 26: 57–64; 2008.
15. Guy RH, Hadgraft J, editors. New York: Marcel Dekker; Transdermal Drug
Delivery.2003.
16. Williams A. London: Pharmaceutical Press; Transdermal and Topical Drug
Delivery. 2003.
17. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of
transdermal drug delivery. Nat Rev Drug Discov., 3:115–124; 2004.
18. Bronaugh RL, Maibach HI, editors. Vol. Edn. 4th. New York: Marcel Dekker.
Percutaneous Absorption. 2005.
19. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL.
Challenges and oppertunities in dermal/transdermal delivery. Therapeutic Delivery.
1:109-131; 2010.
20. Benson HAE. Transdermal drug delivery: Penetration enhancement techniques.
Curr. Drug Delivery., 2:23-33; 2005.
21. Prausnitz M R, Langer R. Transdermal drug delivery. Nat Biotechnol., 26(11):
1261-1268; 2008.
22. Williams AC, Barry BW. Penetration enhancers, Adv Drug Deliv Rev., 56:603-
618; 2004.
23. Tachibana K. Transdermal delivery of insulin to alloxan-diabetic rabbits by
ultrasound exposure, Pharm Res., 9: 952-954; 1992.
24. Lee WR, Shen SC, Wang KH, Hu CH, Fang JY, The effect of laser treatment on
skin to enhance and control transdermal delivery of 5-fluorouracil, J Pharm
Sci.,91:1613-1626; 2002.
References
110
25. Barry BW. Breaching the skin's barrier to drugs, Nat Biotechnol., 22:165-167;
2004.
26. Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers
by high-throughput screening, Nat Biotechnol., 22:192-197; 2004.
27. Sullivan SP, Murthy N, Prausnitz MR, Minimally invasive protein delivery with
rapidly dissolving polymer microneedles, Adv Mater., 20: 933-938; 2008.
28. Lopes LB, Brophy CM, Furnish E, Flynn CR, Sparks O, Komalavilas P, Joshi L,
Panitch A, Bentley MV. Comparative study of the skin penetration of protein
transduction domains and a conjugated peptide. Pharm Res., 22:750-757; 2005.
29. Shin J, Shin K, Lee H, Nam JB, Jung JE, Ryu JH, Han JH, Suh KD, Kim YJ,
Shim J, Kim J, Han SH, Char K, Kim YK, Chung JH, Lee MJ, Kang BC, Kim JW.
Non-invasive transdermal delivery route using electrostatically interactive
biocompatible nanocapsules. Adv Mater., 22:739-743; 2010.
30. Zaro J, Shen WC. Quantitative comparison of membrane transduction and
endocytosis of oligopeptides. Biochem Biophys Res Commun., 307: 241–247; 2003.
31. Sapra B, Jain S, Tiwary AK. Effect of Asparagus racemosus extract on
transdermal delivery of carvedilol: amechanistic study. AAPS Pharm Sci Tech.
10:199–210; 2009.
32. Smith J, Wood E, Dornish M. Effect of chitosan on epithelial cell tight
junctions. Pharm Res., 21: 43–49; 2004.
33. He W, Guo X, Zhang M. Transdermal permeation enhancement of N-trimethyl
chitosan for testosterone, Int J Pharm., 356: 82–87: 2008.
34. Biruss B, Valenta C. Skin permeation of different steroid hormones from
polymeric coated liposomal formulations. Eur J Pharm Biopharm., 62:210–219; 2006.
35. Bolzinger MA, Briancon S, Chevalier Y. Nanoparticles through skin:
managing conflicting results of inorganic and organic particles in cosmetics and
pharmaceutics. WIREs Nanomed Nanobiotechnol., 3,463–478 DOI:
10.1002/wnan.146; 2011.
36. Flynn GL. In Percutaneous absorption, Bronaugh, R.L.; Maibach, H.I., Eds.
Marcel Dekker Inc. New York. 17-52; 1985.
References
111
37. Kasting GB, Smith RL, Anderson BD. In Prodrugs: topical and ocular drug
delivery, Sloan K. Ed. Marcel Dekker Inc. New York. 117-161; 1992.
38. Potts RO, Guy RH. Predictining skin permeability. Pharm Res., 9:663-669;
1992.
39. Higuchi T. Physical chemical analysis of percutaneous absorption process from
creams and ointments. Soc Cosmet Chem., 11:85-97; 1960.
40. Higuchi WI. Analysis of data on the medicament release from ointments. J
Pharm Sci., 51: 802-804; 1962.
41. Mathur V, Sathrawala Y, Rajput MS. Physical and chemical penetration
enhancers in transdermal drug delivery system. Asian J Pharm., 4:173-183; 2010.
42. Wertz PW, Downing DT. In Transdermal drug delivery: developmental issues
and research iniatives. Hadgraft J, Guy RH, Eds. Marcel Dekker Inc.: New York. 1-
22; 1989.
43. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev., 51:702-747.
1971.
44. Katz M, Poulsen BJ, In Handbook of Experimental Pharmacology, Brodie BB,
Gilette J, Eds. Springer Verlag: Berlin.103-174; 1971.
45. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical
compounds and drugs. Exp Dermatol., 9:165-169; 2000.
46. Vyas SP, Khar RK. Transdermal drug delivery, In controlled drug delivery
concepts and advances, Vallabh Prakashan, 1st Ed, 411-447; 2002.
47. Walters KA, Walker M, Olejnik O. J. Nonionic surfactant effect on hairless
mouse skin permeability characteristics. Pharm Pharmacol., 40:525-529; 1988.
48. Wotton PK, Mollgaard B, Hadgraft J, Hoelgaard A. Vehicle effect on topical
drug delivery. Int J Pharm., 24, 19-26; 1985.
49. Yamane MA, Williams AC, Barry BW. Terpene penetration enhancers in
propylene glycol/water cosolvent systems: effectiveness and mechanism of action J
Pharm Pharmacol., 47: 978-989; 1995.
References
112
50. Dingler A, Blum RP, Niehus H, Muller RH, Gohla S. Solid lipid nanoparticles
(SLN/Lipopearls)-α pharmaceutical and cosmetic carrier for the application of
vitamin E in dermal products. J Microencapsul., 16:751-767; 1999.
51. Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid
lipid nanoparticles for topical use: occlusive properties and drug targeting to the
upper skin. Eur J Pharm. Biopharm., 49:211-8; 2000.
52. Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug
carriers for topical glucocorticoids. Int J Pharm., 196:165; 2000.
53. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and
microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm., 56:189-196;
2003.
54. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and
nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv
Drug Deliv Rev., 54:131-55; 2002.
55. Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A,
Schafer-Korting MJ. Drug targeting by solid lipid nanoparticles for dermal use. Drug
Target., 10:489-495; 2002.
56. Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in
vitro release and in vivo skin penetration. J Control Rel., 81:225-33; 2002.
57. Wissing SA, Muller RH. Cosmetic applications for solid lipid nanoparticles. Int.
J Pharm., 254:65-68; 2003.
58. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of
liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm.,
228: 43-52; 2001.
59. Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for
tretinoin I. Preparation and properties. Int J Pharm., 234:237-248; 2002.
60. Namdeo A, Jain NK. Niosomal delivery of 5-fluorouracil. J Microencapsul.,
16:731-740; 1999.
References
113
61. Sentjurc M, Vrhovnik K, Kristl J. Liposomes as a topical delivery system: the
role of size on transport studied by the EPR imaging method. J Control Rel., 59:87-
97; 1999.
62. Shahiwala A, Misra A. Studies in topical application of niosomally entrapped
nimesulide. J Pharm Sci., 5:220-225; 2002.
63. Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of
levonorgestrol for effective contraception. J Control Rel., 54:149-165; 1998.
64. Biana G, Touitou E. Ethosomes: new prospects in transdermal delivery. Crit Rev
Ther Drug Carrier Syst., 20:63-102; 2003.
65. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCL:
ethosomes vs liposomes. Biomaterials., 21:1879-1885; 2000.
66. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz MJ. Ethosomes: Novel
vesicular carriers for delivery. J Control Rel., 65:403-418; 2000.
67. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F.
Intracellular delivery mediated by an ethosomal carrier. Biomaterials., 22:3053-3059;
2001.
68. Blume G, Cevc G, Crommelin MD, Bakker-Woudenberg IA, Kluft C, Storm G.
Specific targeting with poly (ethylene glycol)-modifeied liposomes: coupling of
homing devices to the ends of the polymeric chains combines effective target binding
with long circulation times. Biochim Biophys Acta., 1149:180-184; 1993.
69. Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G. Ultraflexible vesicles,
transfersomes, have an extremely low pore penetration resistance and transport
therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys
Acta., 1368:201-215; 1998.
70. Cevc G, Blume G. New highly efficient formulation of diclofenac for the topical,
transdermal administration in ultradeformable drug carriers, transfersomes. Biochim.
Biophys. Acta., 1514:191-205; 2001.
71. Cevc G, Blume G. Biological activity and characteristics of triamcinolone-
acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim.
Biophys. Acta., 1614:156-164; 2003.
References
114
72. Kreuter J, Speiser PP. In vitro studies of poly (methyl methacrylate) adjuvants. J
Pharm Sci., 65:1624–1627; 1976.
73. Couvreur P, Kante B, Roland M, Guiot P, Bauduin P, Speiser P.
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers:
preparation,morphological and sorptive properties. J Pharm Pharmacol., 31: 331–332;
1979.
74. Marty JJ, Oppenheim RC, Speiser P. Nanoparticles-A new colloidal drug
delivery system. Pharm Acta Helv., 53:17–23; 1978.
75. Marcos Garcia-Fuentes, Maria J. Alonso. Chitosan-based drug nanocarriers:
Where do we stand?, http://dx.doi.org/10.1016/j.jconrel.2012.03.017.
76. Mosgoeller W, Prassl R, Zimmer A. Nanoparticle-Mediated Treatment of
ulmonary Arterial Hypertension, Chapter 7, Methods in Enzymology. Volume 508 ,
Elsevier Inc. 325-350; 2012.
77. Kumaresh S. Soppimatha, Tejraj M. Aminabhavia, Anandrao R. Kulkarnia,
Walter E. Rudzinski. Biodegradable polymeric nanoparticles as drug delivery
devices.J Control Rel., 70:1–20; 2001.
78. Langer R. Biomaterials in drug delivery and tissue engineering: One laboratory’s
experience. Acc Chem Res., 33:94-101; 2000.
79. Lanza RP, Langer R, Chick WL. Principles of Tissue Engineering, in: Academic
Press, Austin, TX, 405-427; 1997.
80. Gupta RB, Kompella UB. Nanoparticle Technology for drug delivery. Drugs and
the Pharmaceutical Sciences, Taylor & Francis. 159; 2006.
81. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in
cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the
antitumor agent Smancs. Cancer Res., 46:6387–6392; 1986.
82. Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug
targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res., 44:
2115– 2121; 1984.
References
115
83. Maeda H, Matsumoto T, Konno T, Iwai K, Ueda M. Tailor-making of protein
drugs by polymer conjugation for tumor targeting: a brief review on Smancs. J Prot
Chem., 3: 181–193; 1984.
84. Maeda H. The enhanced permeability and retention (EPR) effect in tumor
vasculature: The key role of tumor selective macromolecular drug targeting. Advan
Enzyme Regul., 41:189–207; 2001.
85. Savita B, Amarnath M. Dextran–doxorubicin/chitosan nanoparticles for solid
tumor therapy. Nanomed Nanobiotechnol., 1: 415-425; 2009.
86. Reinhard HH Neubert. Potentials of new nanocarriers for dermal and
transdermal drug delivery. Eur J Pharmaceut Biopharmaceut., 77:1-2; 2011.
87. Schroeter A, Engelbrecht T, Reinhard HH Neubert, Goebel ASB. New nanosized
technologies for dermal and transdermal drug delivery. a review. J Biomed
Nanotech., 6:511-528; 2010.
88. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of
topical delivery from biodegradable nanoparticles. Pharm Res., 21 (10):1818–1825;
2004.
89. Luengo J. Human skin drug delivery using biodegradable PLGA-nanoparticles.
Saarland University, 2007.
90. Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, Konig K, Kostka KH,
Lehr CM, Schaefer UF. Influence of nanoencapsulation on human skin transport of
flufenamic acid. Skin Pharmacol Physiol., 19 (4):190–197; 2006.
91. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi
U.Penetration profile of microspheres in follicular targeting of terminal hair follicles.
J Invest Dermatol., 123 (1):168–176; 2004.
92. Alvarez-Roman R, Naik A, Kalia Y, Guy RH, Fessi H. Skin penetration and
distribution of polymeric nanoparticles. J Control Rel., 99 (1):53-62; 2004.
93. Byrne ME, Park K, Peppas NA. Molecular imprinting within hydrogels. Adv
Drug Deliv Rev., 54:149–161; 2002.
94. Kopecek J. Polymer chemistry: swell gels. Nature. 417:388–91; 2002.
References
116
95. Brandl F, Sommer F, Goepferich A. Rational design of hydrogels for tissue
engineering: impact of physical factors on cell behavior. Biomaterials., 28:134–146;
2007.
96. Hoffman AS. Applications of thermally reversible polymers and hydrogels in
therapeutics and diagnostics. J Control Rel., 6:297–305; 1987.
97. Kabanov AV, Gendelman HE. Nanomedicine in the diagnosis and therapy of
neurodegenerative disorders. Progr Polym Sci., 32:1054–1082; 2007.
98. Langer R, Vacanti JP. Tissue engineering. Science. 260:920–926, 1993.
99. Langer R. Drug delivery. Drugs on target. Science. 293:58–59; 2001.
100. Lutz JF, Boerner HG. Modern trends in polymer bioconjugates design. Progr
Polym Sci., 33:1–39; 2008.
101. Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydrogels in biology and
medicine: from molecular principles to bionanotechnology. Adv Mater., 18:1345–
1360; 2006.
102. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug
delivery. Progr Polym Sci., 32:962–990; 2007.
103. Wichterle O, Lim D. Hydrophilic gels for biological use. Nature. 185:117–118;
1960.
104. Mehrdad H, Amir A, Pedram R. Hydrogel nanoparticles in drug delivery. Adv
Drug Deliv Rev., 60:1638–1649; 2008.
105. Peppas NA, Khare AR. Preparation, structure and diffusional behavior of
hydrogels in controlled release. Adv Drug Del Rev., 11:1–35; 1993.
106. Blanco MD, Garcia O, Trigo RM, Teijon JM, Katime I. 5-Fluorouracil release
from copolymeric hydrogels of itaconic acid monoester I. Acrylamide-co-
monomethyl itaconate, Biomaterials. 17:1061-1067; 1996.
107. Ratner BD, Hoffman AS. Synthetic hydrogels for biomedical applications, in
J.D. Andrade (Ed.), Hydrogels for Medical and Related Applications, ACS
Symposium Series, American Chemical Society. 31:1–36; 1976.
108. Amsden B. Solute diffusion within hydrogels. Mechanisms and models.
Macromolecules. 31:8382–8395; 1998.
References
117
109. Canal T, Peppas NA. Correlation between mesh size and equilibrium degree of
swelling of polymeric networks. J Biomed Mater Res., 23:1183–1193; 1989.
110. Silan C, Akcalib A, Otkunb MT, Ozbeyb N, Butunc S, Ozayc O, Sahinerc N.
Novel hydrogel particles and their IPN films as drug delivery systems with
antibacterial properties. Colloids Surf B., 89: 248-253; 2012.
111. Morimoto K, Nagayasu A, Fukanoki S, Morisaka K, Ikada Y. Evaluation of
polyvinyl alcohol hydrogel as a sustained-release vehicle for rectal administration of
indomethacin. Pharm Res., 6:338–341; 1989.
112. Jeyanthi R, Nagarajan B, Panduranga KR. Solid tumor chemotherapy using
implantable collagen-poly (HEMA) hydrogel containing 5-fluorouracil. J Pharm
Pharmacol., 43:60–62; 1991.
113. Patel VR, Amiji MM. Preparation and characterization of freeze dried chitosan
poly (ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach.
Pharm Res. 13:588–593; 1996.
114. Vervoort L, Vinckier I, Moldenaers P, Van den Mooter G, Augustijns P, Kinget
R. Inulin hydrogels as carriers for colonic drug targeting. Rheological
characterization of the hydrogel formation and the hydrogel network. J Pharm Sci.,
88:209–214; 1999.
115. Wu J, Wei W, Wang LY, Su ZG, Ma GH. A thermosensitive hydrogel based on
quaternized chitosan and poly (ethylene glycol) for nasal drug delivery system.
Biomaterials. 28:2220–2232; 2007.
116. Chaterji S, Kwon I, Park K. Smart polymeric gels: Redefining the limits of
biomedical devices. Prog Polym Sci., 32:1083–1122; 2007.
117. Qiao ZY, Zhang R, Du FS, Liang DH, Li ZC. Multi-responsive nanogels
containing motifs of ortho ester, oligo (ethylene glycol) and disulfide linkage as
carriers of hydrophobic anti-cancer drugs. J Control Rel., 152 57–66; 2011.
118. Kabanov AV, Vinogradov S. Nanogels as pharmaceutical carriers: finite
networks of infinite capabilities. Angew Chem Int Ed., 48:5418-5429; 2009.
119. Koen R, Joseph D, Stefaan De S. Advanced Nanogel Engineering for drug
delivery. Soft Matter. 5:707-715; 2009.
References
118
120. Sungwon K, Kyong Mi P, Jin Young K, Ick C K, Hyeon GC, Dongmin K, In
TY, Kwangmeyung K, Kun N. Minimalism in fabrication of self-organized nanogels
holding both anti-cancer drug and targeting moiety. Colloids Surf B., 63:55–63; 2008.
121. An Z, Qiu Q, Liu G. Synthesis of architecturally well defined nanogel via RAFT
polymerization for potential bioapplications. Chem Commun., 47:12424-12440;
2011.
122. Motornov M, Roiter Y, Tokarev I, Minko S. Stimuli-responsive nanoparticles,
nanogels and capsules for integrated multifunctional intelligent systems. Prog Polym
Sci., 35:174–211; 2010.
123. Hendrickson GR, Smith MH, South AB, Lyon LA. Design of multiresponsive
hydrogel particles and assemblies. Adv Funct Mater., 20:1697–1712; 2010.
124. Seo S, Lee CS, Jung YS, Na K. Thermo-sensitivity and triggered drug release of
polysaccharide nanogels derived from pullulan-g-poly(l-lactide) copolymers.
Carbohydr Polym., 87:1105-1111; 2012.
125. Maria D. Moya-Ortegaa, Carmen Alvarez-Lorenzob, Hákon H. Sigurdssona,
Angel Concheirob, Thorsteinn Loftssona. Cross-linked hydroxypropyl-β-cyclodextrin
and γ-cyclodextrin nanogels for drug delivery: Physicochemical and loading/release
properties. Carbohydr Polym., 87:2344-2351; 2012.
126. Wu W, Aiello M, Zhou T, Berliner A, Banerjee P, Zhou S. In-situ
immobilization of quantum dots in polysaccharide-based nanogels for integration of
optical pH-sensing, tumor cell imaging, and drug delivery. Biomaterials. 31:3023–
3031; 2010.
127. Wu W, Shen J, Banerjee P, Zhou S. Water-dispersible multifunctional hybrid
nanogels for combined curcumin and photothermal therapy. Biomaterials. 32:598-
609; 2011.
128. Li N, Jinli Wang, Xingguo Yang, Lingbing Li. Novel nanogels as drug delivery
systems for poorly soluble anticancer drugs. Colloids Surf B., 83:237-244; 2011.
129. Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the
cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 33:1607-1617;
2012.
References
119
130. Xie C, Gou ML, Yi T, Deng H, Li ZY, Liu P, Qi XR, Zhao X. Efficient
inhibition of ovarian cancer by truncation mutant of FILIP 1L gene delivered by
novel biodegradable cationic heparin- polyethyleneimine nanogels. Hum Gene Ther.,
22:1413-1422; 2011.
131. Zhao M, Biswas A, Hud B, Joo K II, Wang P, Gu Z, Tang Y. Redox-responsive
nanocapsules for intracellular protein delivery. Biomaterials. 32:5223-5230; 2011.
132. Kang H, Trondoli AC, Zhu G, Chen Y, Chang YJ, Liu H, Huang YF, Tan W.
Near-infrared light-responsive core-shell nanogels for targeted drug delivery. ACS
Nano., 5:5094-5099; 2011.
133. Murphy EA, Majeti BK, Mukthavaram R, Acevedo LM, Barnes LA, Cheresh
DA. Targeted nanogels: A versatile platform for drug delivery to tumors. Mol Cancer
Ther., 10:972-982; 2011.
134. Zha L, Banik B, Alexis F.Stimulus responsive nanogels for drug delivery. Soft
Matter. 7: 5908-5916; 2011.
135. Du FS, Wang Y, Zhang R, Li ZC. Intelligent nucleic acid delivery systems
based on stimuli-responsive polymers. Soft Matter. 6:835–848; 2010.
136. Hu YH, Atukorale PU, Lu JJ, Moon JJ, Um SH, Cho EC, Wang Y, Chen JZ,
Irvine DJ. Cytosolic delivery mediated via electrostatic surface binding of protein,
virus, or siRNA cargos to pH-responsive core-shell gel particles, Biomacromolecules.
10:756–765; 2009.
137. Kim JO, Kabanov AV, Bronich TK. Polymer micelles with cross-linked
polyanion core for delivery of a cationic drug doxorubicin. J Control Rel., 138:197–
204; 2009.
138. Lee ES, Gao ZG, Bae YH. Recent progress in tumor pH targeting
nanotechnology. J Control Rel., 132:164–170; 2008.
139. Oishi M, Hayashi H, Michihiro ID, Nagasaki Y. Endosomal release and
intracellular delivery of anticancer drugs using pH-sensitive PEGylated nanogels. J
Mater Chem., 17: 3720-3725; 2007.
140. Berndt I, Pedersen JS, Richtering W. Structure of multiresponsive “intelligent”
core-shell microgels. J Am Chem Soc., 127:9372–9373; 2005.
References
120
141. Lee Y, Park SY, Kim C, Park TG. Thermally triggered intracellular explosion of
volume transition nanogels for necrotic cell death. J Control Rel., 135: 89–95; 2009.
142. Nagahama K, Hashizume M, Yamamoto H, Ouchi T, Y. Ohya Y.
Hydrophobically modified biodegradable poly (ethylene glycol) copolymers that form
temperature- responsive nanogels. Langmuir. 25:9734–9740; 2009.
143. Lee H, Mok H, Lee S, Oh YK, Park TG. Target-specific intracellular delivery of
siRNA using degradable hyaluronic acid nanogels. J Control Rel., 119:245–252;
2007.
144. Li YL, Zhu L, Liu ZZ, Cheng R, Meng FH, Cui JH, Ji SJ, Zhong ZY.
Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver
doxorubicin into the nuclei of cancer cells. Angew. Chem. Int. Ed., 48: 9914–9918;
2009.
145. Ryu JH, Jiwpanich S, Chacko R, Bickerton S, Thayumanavan S.
Surfacefunctionalizable polymer nanogels with facile hydrophobic guest
encapsulation Capabilities. J Am Chem Soc., 132:8246–8247; 2010.
146. Morinloto N, Qiu XP, Winnik FM, Akiyoshi K. Dual stimuli-responsive
nanogels by self-assembly of polysaccharides lightly grafted with thiol-terminated
poly(Nisopropylacrylamide) chains. Macromolecules., 41:5985–598; 2008.
147. Zhang JY, Jiang X, Zhang YF, Li YT, Liu SY. Facile fabrication of reversible
core cross-linked micelles possessing thermosensitive swellability. Macromolecules.,
40: 9125-9132; 2007.
148. Bauhuber S, Hozsa C, Breunig M, Gopferich A. Delivery of nucleic acids via
disulfide-based carrier systems. Adv Mater., 21:3286–3306; 2009.
149. Du JZ, Sun TM, Song WJ, Wu J, Wang J. A tumor- tumor-acidity-activated
chargeconversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake
and drug delivery. Angew Chem Int Ed., 49:3621–3626; 2010.
150. Meng FH, Hennink WE, Zhong Z. Reduction-sensitive polymers and
bioconjugates for biomedical applications. Biomaterials. 30:2180–2198; 2009.
References
121
151. Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via
reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug
Deliv Rev., 55:199–215; 2003.
152. Chang C, Wei H, Feng J, Wang ZC, Wu XJ, Wu DQ, Cheng SX, Zhang XZ,
Zhuo RX. Temperature and pH double responsive hybrid cross-linkedmicelles based
on p (NIPAAm-co-MPMA)-b-p(DEA): RAFT synthesis and “schizophrenic”
micellization. Macromolecules. 42: 4838–4844; 2009.
153. Chung JE, Yokoyama M, Okano T. Inner core segment design for drug delivery
control of thermo-responsive polymeric micelles. J Control Rel., 65:93–103; 2000.
154. Huang XN, Du FS, Cheng J, Dong YQ, Liang DH, Ji SP, Lin SS, Li ZC.
Acidsensitive polymeric micelles based on thermoresponsive block copolymers with
pendent cyclic orthoester groups. Macromolecules. 42:783–790; 2009.
155. Rijcken CJF, Soga O, Hennink WE, van Nostrum CF. Triggered destabilisation
of polymeric micelles and vesicles by changing polymers polarity: an attractive tool
for drug delivery. J Control Rel., 120:131–148; 2007.
156. Soga O, van Nostrum CF, Fens M, Rijcken CJF, Schiffeler RM, Storm SG,
Hennink WE. Thermosensitive and biodegradable polymeric micelles for paclitaxel
Delivery. J Control Rel., 103:341–353; 2005.
157. R. Jayakumar, Amrita Nair, N. Sanoj Rejinold, S. Maya, S. V. Nair.
Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells.
Carbohydr polym. 87:2352-2356; 2012
158. Inmaculada A, Marian M, Ruth H, Inés P, Beatriz M, Niuris A, Gemma G,
Ángeles H. Functional characterization of chitin and chitosan. Curr Chem Biol.,
3:203-230; 2009.
159. Tamura H, Furuikea T, Nair SV, Jayakumar R. Biomedical applications of chitin
hydrogel membranes and scaffolds. Carbohydr Polym., 84:820–824; 2011.
160. Raabe D, Romanoa P, Sachs C, Fabritius H, Al-Sawalmih, Yi SB, Servos G,
Hartwig HG. Microstructure and crystallographic texture of the chitin–protein
network in the biological composite material of the exoskeleton of the lobster
Homarus americanus. Mater Sci Eng., A 421:143-153; 2006.
References
122
161. Yimin F, Tsuguyuki S, Akira I. Chitin nanocrystals prepared by TEMPO-
mediated oxidation of α-chitin. Biomacromolecules. 9: 192-198; 2008a.
162. Yimin Fan, Tsuguyuki Saito and Akira Isogai. Preparation of Chitin Nanofibers
from Squid pen β-chitin by simple mechanical treatment under acid conditions.
Biomacromolecules. 9:1919-1923; 2008b.
163. Feisal Khoushab, Montarop Yamabhai. Chitin Research Revisited. Mar Drugs.,
8: 1988-2012; 2010.
164. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-
phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study
in rats. Int J Pharm., 330:155-163; 2007.
165. Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and
characterization of curcuminoids loaded solid lipid nanoparticles. Int. J
Pharmaceutics., 337:299-306; 2007.
166. Preetha A, Chithra S, Sonia J, Ajaikumar BK, Aggarwal BB. Curcumin and
cancer: An ‘‘old-age” disease with an ‘‘age-old” solution. Cancer Lett., 267:133-164;
2008.
167. Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: How many
ways can curry kill tumor cells selectively? AAPS J., 11:495-510; 2009.
168. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of
anticancer properties and therapeutic activity in head and neck squamous cell
carcinoma. Mol. Cancer., 10:12; 2011.
169. Bachar Z, Zephirin M, Virginie N. Stabilization of curcumin by complexation
with divalent cations in glycerol/ water system. Bioinorg Chem Appl.,
doi:10.1155/2010/292760; 2010.
170. Paul A. Mccarron, David Woolfson A, Siobhaan M. Keating. Sustained release
of 5-Fluorouracil from polymeric nanoparticles. J Pharm Pharmacol., 52: 1451-1459;
2000.
171. Saif MW, Syrigos KN, Katirtzoglou NA. A promising new oral fluoropyrimidine
derivative. Expert Opin Invest Drugs., 18:335-348; 2009.
References
123
172. Raje Chouhan, Bajpai AK. An in vitro release study of 5-fluoro-uracil (5-FU)
from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles. J Mater
Sci., 20:1103-1114; 2009.
173. Singh BN, Singh RB, Singh J. Effect of ionization and penetration enhancers on
the transdermal delivery of 5-Fluorouracil through excised human stratum corneum.
Int J Pharm., 298:98-107; 2005.
174. Singh BN, Jayaswal SB. Iontophoretic delivery of 5-fluorouracil through excised
human stratum corneum. Drug Discov Ther., 2:128-135; 2008.
175. Kong M, Chen XG, Kweon DK and Park HJ. Investigations on skin permeation
of hyaluronic acid based nanoemulsion as transdermal carrier. Carbohydr Polym., 86:
837-843; 2010.
176. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H and Couvreur P.
Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev., 55; 519-548;
2003.
177. Tamura H, Nagahama H, Tokura S. Preparation of hydrogels under mild
conditions. Cellulose.13:357; 2006.
178. Rejinold NS, Chennazhi KP, Tamura H, S. Nair SV, Jayakumar R.
Multifunctional chitin nanogels for simultaneous drug delivery, bioimaging and
biosensing. ACS Appl Mater Interfaces., 3:3654–3665; 2011.
179. Ji L, Yunyun J, Jun W, Guorong F, Yutian W, Chuan Z. A rapid and simple
HPLC method for the determination of curcumin in rat plasma: assay development,
validation and application to a pharmacokinetic study of curcumin liposome. Biomed
Chromatogr., 23:1201-1207; 2009.
180. Rejinold NS, Sreerekha PR, Chennazhi KP, Nair SV, Jayakumar R.
Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-
isopropylacrylamide) nanocarrier for curcumin drug delivery. Int J Biiol Macromol.,
49:161-172; 2011.
181. Alsarra IA, Alarifi MN. Validated liquid chromatographic determination of 5-
fluorouracil in human plasma. J Chromatogr B., 804:435-439; 2004.
References
124
182. Zweers ML, Engbers GH, Grijpma DW, Feijen J. In vitro degradation of
nanoparticles prepared from polymers based on DL-lactide, glycolide and poly
(ethylene oxide). J Control Rel., 100:347-356; 2004.
183. Pangburn SH, Trescony PV, Heller J. Lysozyme degradation of partially
deacetylated chitin, its films and hydrogels. Biomaterials. 3:105-108; 1982
184. Helena S, Azevedo and Rui L. Reis. Understanding the enzymatic degradation
of biodegradable polymers and strategies to control their degradation rate. Chapter
12. Biodegradable Systems in Tissue Engineering and Regenerative Medicine. 178-
197.
185. Shigemasa Y, Saito K, Sashiwa H, Saimoto H. Enzymatic degradation of
chitins and partially deacetylated chitins. Int. J. Biol. Macromol., 16:43-49; 1994.
186. Changcheng He , Kexin Jiao , Xu Zhang , Mei Xiang , Zhiyong Li and
Huiliang Wang. Nanoparticles, microgels and bulk hydrogels with very high
mechanical strength starting from micelles.
Soft Matter.7: 2943-2952; 2011.
187. Li N, Wang J, Yang X, Li L. Novel nanogels as drug delivery systems for poorly
soluble anticancer drugs. Colloids Surf., B., 83:237–244; 2011.
188. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH
is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci.,
5:359-370; 2006.
189. Anitha A, Chennazhi KP, Nair SV, Jayakumar R. 5-Flourouracil loaded N,O-
carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast
cancer. J Biomed Nanotechnol. 8:1-14; 2012.
190. Rejinold NS, Muthunarayanan M, Chennazhi KP, Jayakumar R. Curcumin
loaded fibrinogen nanoparticles for cancer drug delivery. J Biomed Nanotechnol.,
2011,7:521-534.
191. Schaefer UF, Hansen S, Schneider M, Luengo J, Claus C, Lehr M. Models for
skin absorption and skin toxicity testing, in Drug Absorption Studies In Situ, In Vitro
and In Silico Models, ed. C. Ehrhardt and K.-J. Kim. Springer International Edition.
3–24; 2010.
References
125
192. Bronaugh RL, Stewart RF, Congdon IR, Methods for in vitro percutaneous
absorption studies II. Animal models for human skin, Toxicol. Appl. Pharmacol.,
1982, 62: 481–488.
193. Fritz PS, Josef GM, Andreas B. Comparison of human skin or epidermis models
with human and animal skin in in vitro percutaneous absorption. Int J Pharm.,
215:51–56; 2001.
194. Raabe H, Curren R, Ward S, Harbell J, Report from an in vitro dermal absorption
assay workshop in In Vitro Percutaneous Absorption Expert-Users Workshop,
Gaithersburg, USA, 2005.
195. Organisation for Economic Co-operation and Development (OECD), “Skin
Absorption: In Vitro Method”, OECD Environment Directorate, OECD Guideline for
the Testing of Chemicals, Guideline 428, Paris, adopted May 2002, official
publication February 2004.
196. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TSJ, Lambert PA.
Penetration of chlorhexidine into human skin. Antimicrob Agents Chemother.,
52:3633–3636; 2008.
197. Park K. Nanotechnology: What it can do for drug delivery. J Control Rel., 120:
1– 3; 2007.
198. Jayakumar R, Chennazhi KP, Nair SV, Sanoj Rejinold N, The art, method,
manner, process and system of preparation of alpha chitin nanogels for drug delivery
and imaging applications, Indian Patent No. 357/CHE/2011 A; 2011.
199. Salaun Fabien, Vroman Isabelle. Curcumin loaded nanocapsules: formulation
and influence of the nanoencapsulation processes variables on the physico-chemical
characteristics of the particles. Int J Chem React Eng., 7: A55; 2009.
200. Anitha A, Deepagan VG, Divya Rani VV, M. Deepthy M, Nair SV, Jayakumar
R. Preparation, characterization, in vitro drug release and biological studies of
curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym.,
84:1158–1164; 2011.
201. Rejinold NS, Muthunarayanan M, Divyarani VV, Sreerekha PR, Chennazhi
KP, Nair SV, Tamura H, Jayakumar R. Curcumin-loaded biocompatible thermo
References
126
responsive polymeric nanoparticles for cancer drug delivery. J Colloid Interface Sci.,
360: 39-51; 2011.
202. Yassin AEB, Anwer MK, Mowafy HA, El-Bagory IM, Bayomi MA, Alsarra IA.
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat
colon cancer. J Med Sci., 7:398-408; 2010.
203. Sorina Alexandra Garea, Adi Ghebaur, Corina and Ronescu. Systems based on
dendrimers and antitumoral drug synthesized by non-covalent method: The influence
of dendrimers generation. Materiale Plastice. 48: 17-22; 2011.
204. Rejinold NS, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Biodegradable
and thermo-sensitive chitosan-g-poly (N-vinylcaprolactam nanoparticles as a 5-
fluorouracil carrier. Carbohydr Polym. 83: 776-786; 2011b.
205. Anitha A, Chennazhi KP, Nair SV, Jayakumar R. 5-Flourouracil loaded N, O-
carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast
cancer. J Biomed Nanotechnol., 8:1-14; 2012.
206. Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide
nanoparticles for targeted drug delivery. Mater Sci Eng C., 30: 484–490; 2010.
207. Jaykumar R, Tamura H. Synthesis, characterization and thermal properties of
chitin-g-poly (ε-caprolactone) copolymers by using chitin gel. International Journal of
Biological Macromol., 3: 32-36; 2008.
208. Koen R, Joseph D, Stefaan De S. Advanced nanogel engineering for drug
delivery. Soft Matter. 5:707-715; 2009.
209. Murray SB, Neville AC. The role of pH, temperature and nucleation in the
formation of cholesteric liquid crystal spherulites from chitin and chitosan. Int. J Biol.
Macromol., 22:137-144; 1998.
210. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY and Lin JK. Stability
of curcumin in buffer solutions and characterization of its degradation products, J.
Pharm. Biomed. Anal., 15; 1867–1876:1997.
211. Raemdonck K, Demeester J, De Smedt S. Advanced nanogel
engineering for drug delivery, Soft Matter., 5: 707–715; 2009.
References
127
212. Syng-Ai, Kumari AL, Khar A, Effect of curcumin on normal and tumor cells:
role of glutathione and bcl-2. Mol. Cancer Ther., 3, 1101–1108; 2004.
213. Seda Tıglı Aydın R & Mehlika Pulat. 5-Fluorouracil encapsulated chitosan
nanoparticles for pH-stimulated drug delivery: evaluation of controlled release
kinetics. J. Nanomaterials 2012; Article ID 313961, 10 pages,
doi:10.1155/2012/313961, 2012.
214. Cenni E, Granchi D, Avnet S, Fotia C, Salerno M, Micicli D, Sarpietro M G,
Pignatello R, Castelli F, Baldini N. Biocompatibility of poly(D-L lactide co-
glycolide) nanoparticles conjugated with alendrnate. Biomaterials. 29:1400-1411;
2008.
215. Jiao Y, Ubrich N, Marchand Arvier M, Vigneron C, Hoffman M, Lecompte T,
Maincent P. In vitro and in vivo evaluation of oral heparin-loaded polymeric
nanoparticles in rabbits. Circulation.105: 230-235; 2002.
216. Yu Zhang, Mo Yang, Nathaniel G. Portney, Daxiang Cui, Gurer Budak, Ekmel
Ozbay, Mihrimah Ozkan & Cengiz S. Ozkan. Zeta potential: a surface electrical
characteristic to probe the interaction of nanoparticles with normal and cancer human
breast epithelial cells. Biomed Microdevices. 10:321-328; 2008.
217. Cengelli F, Voinesco F, Juillerat-Jeanneret L. Interaction of cationic ultrasmall
superparamagnetic iron oxide nanoparticles with human melanoma cells.
Nanomedicine, 5:1075-1087; 2010.
218. Tore-Geir Iversen, Tore Skotland, Kirsten Sandvig. Endocytosis and
intracellular transport of nanoparticles: Present knowledge and need for future
studies. Nano Today. 6:176-185; 2011.
219. Zauner W, Ogris M, Wagner E. Polylysine-based transfection systems utilizing
receptor-mediated delivery. Adv Drug Delivery Rev., 30:97-113; 1998.
220. Garnett MC. Gene-delivery systems using cationic polymers. Crit Rev Ther
Drug Carrier Syst., 16:147-207; 1999.
221. Shishodia S, Amin HM, Lai R, Aggarwal BB, Curcumin (diferuloylmethane)
inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses
References
128
proliferation, and apoptosis in mantle cell lymphoma, Biochem Pharmacol., 70: 700-
713; 2005.
222. Watson JL, Hill R, Lee PW, Giacomantonio CA, Hoskin DW. Curcumin induces
apoptosis in HCT-116 human colon cancer cells. Chem Mater., 2008, 21, 2851–2861.
223. Scharstuhl A, Mutsaers HA, Pennings SW, Szarek WA, Russel FG, Wagener
FA. Curcumin induced fibroblast apoptosis and in vitro wound contraction are
regulated by antioxidants and heme oxygenase: implications for scar formation. J Cell
Mol Med., 13:712–725; 2009.
224. Ngo DN, Lee SH, Kim MM, Kim SK, Production of chitin oligosaccharides with
different molecular weights and their antioxidant effect in RAW 264.7 cells. J Funct
Foods., 1:188-198; 2009.
225. Moon -Moo Kim & Se- Kwon Kim. Anti inflammatory activity of chitin,
chitosan and their derivatives. In Chitin,chitosan, oligosaccharides and their
derivatives- Biological activities and applications, edited by Se-Kwon Kim. CRC
press, 215-221; 2010.
226. Jolanta Kumirska, Mirko X. Weinhold, Jorg Thöming and Piotr Stepnowski.
Biomedical activity of chitin/chitosan based materials- influence of physicochemical
properties apart from molecular weight and degree of N-acetylation.
Polymers.3:1875-1901; 2011.
227. De Angelis PM, Svendsrud DH, Kravik KL, Stokke T. Cellular response to 5-
fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and
recovery. Molecular Cancer 2006, 5:20 doi:10.1186/1476-4598-5-20
228. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in
deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependant
manner. J Biol Chem., 280:20059-20068; 2005.
229. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program
in cell-free extracts: requirement for dATP and cytochrome C, Cell. 86:147–157;
1996.
References
129
230. Liu E, Wu J, Cao W, Zhang J, Liu W, Jiang X , Zhang X. Curcumin induces
G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression
in human glioma. J Neuro-Oncol., 85:263–270; 2007.
231. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M,
Tridandapani S, Anant S, Kuppusamy P. Curcumin induces G2/M arrest and
apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and
p38 MAPK. Cancer Biol Ther., 6:178–184; 2007.
232. Gajate C, Mollinedo F. Cytoskeleton-mediated death receptor and ligand
concentration in lipid rafts forms apoptosis-promoting clusters in cancer
chemotherapy. J Biol Chem., 280:11641-11647; 2005.
233. Lu HF, Lai KC, Hsu SC, Lin HJ, Yang MD, Chen YL, Fan MJ, Yang JS, P.
Y. Cheng PY, Kuo CL, Chung JG. Curcumin induces apoptosis through FAS and
FADD, in caspase- 3-dependent and -independent pathways in the N18 mouse-rat
hybrid retina ganglion cells. Oncol Rep., 22:97–104; 2009.
234. Zoli W, Ulivil P, Tesei A, Fabbri F, Rosetti M, Maltoni R, Giunchi DC, Ricotti
L, Brigliadori G, Vannini I, Amadori D. Addition of 5-fluorouracil to doxorubicin-
paclitaxel sequence increases caspase dependent apoptosis in breast cancer cell lines.
Breast Cancer Res., 2005, 7, R681-R689.
235. Ballarin B, Galli S, Mogavero F, Morigi M. Effect of cationic charge and
hydrophobic index of cellulose based polymers on the semipermanent dyestuff
process for hair. Int J Cosmet Sci., 33: 228–233; 2011.
236. Barell AO, Paye M, Maibach HI. Handbook of cosmetic science and technology.
Marcel Dekker. 407; 2001.
237. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant
melanoma, the common presence of keratins. Lab Invest., 61:623–628; 1989.
top related